Skip to Main Content

Author Details

Martin Glas
University Hospital Essen
2002
133
31
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
38071569Theranostics in Neurooncology: Heading Toward New Horizons.J Nucl Med2024
36054558A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression.Int J Cancer2023
37627083Telemedicine in Neuro-Oncology-An Evaluation of Remote Consultations during the COVID-19 Pandemic.Cancers (Basel)2023
37853454INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas.Neurol Res Pract2023
37547266Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastoma.Neurooncol Adv2023
37823259Correlation of the apparent diffusion coefficient with the standardized uptake value in meningioma of the skull plane using [68]Ga-DOTATOC PET/MRI.Nucl Med Commun2023
37728779Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses.J Neurooncol2023
37921974Correction to: Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses.J Neurooncol2023
37920861Treatment of acute ischemic stroke in patients with active malignancy: insight from a comprehensive stroke center.Ther Adv Neurol Disord2023
37811538Are we providing best-available care to newly diagnosed glioblastoma patients? Systematic review of phase III trials in newly diagnosed glioblastoma 2005-2022.Neurooncol Adv2023
37385668Evaluation of [<sup>68</sup>Ga]-DOTATOC PET/MRI in Patients with Meningioma of the Subcranial and Intraorbital Space.J Nucl Med2023
37277265Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders' Collaborative Consortium (EORTC 1419).Eur J Cancer2023
37335907Individual glioblastoma cells harbor both proliferative and invasive capabilities during tumor progression.Neuro Oncol2023
37296942Location of Recurrences after Trimodality Treatment for Glioblastoma with Respect to the Delivered Radiation Dose Distribution and Its Influence on Prognosis.Cancers (Basel)2023
37296870BRMS1 in Gliomas-An Expression Analysis.Cancers (Basel)2023
36581374Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities.J Nucl Med2023
36609807Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial.J Neurooncol2023
36239995A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma.Clin Cancer Res2023
35953681Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma.J Cancer Res Clin Oncol2023
34963556The Impact of Tumor Treating Fields on Glioblastoma Progression Patterns.Int J Radiat Oncol Biol Phys2022
35707317Brain tumor patients and COVID-19 vaccines: results of an international survey.Neurooncol Adv2022
35538414Twelve-month safety, tolerability and susceptibility to adverse events of prophylactic migraine therapy with erenumab: a retrospective real-world study.J Headache Pain2022
35599302AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas.Neurol Res Pract2022
35563629Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like Cells.Int J Mol Sci2022
35687795Real-world evidence following a mandatory treatment break after a 1-year prophylactic treatment with calcitonin gene-related peptide (pathway) monoclonal antibodies.Brain Behav2022
35897674Protocadherin Gamma C3 (PCDHGC3) Is Strongly Expressed in Glioblastoma and Its High Expression Is Associated with Longer Progression-Free Survival of Patients.Int J Mol Sci2022
36284931First multicentric real-life experience with the combination of CCNU and temozolomide in newly diagnosed <i>MGMT</i> promoter methylated <i>IDH</i> wildtype glioblastoma.Neurooncol Adv2022
35045869Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial.Trials2022
33389825Dosimetric impact of the positioning variation of tumor treating field electrodes in the PriCoTTF-phase I/II trial.J Appl Clin Med Phys2021
33789203Leptomeningeal disease from melanoma-Poor prognosis despite new therapeutic modalities.Eur J Cancer2021
33502678Machine learning-based differentiation between multiple sclerosis and glioma WHO II°-IV° using O-(2-[18F] fluoroethyl)-L-tyrosine positron emission tomography.J Neurooncol2021
33604462Detect it so you can treat it: A case series and proposed checklist to detect neurotoxicity in checkpoint therapy.eNeurologicalSci2021
34944806Fully Automated MR Based Virtual Biopsy of Cerebral Gliomas.Cancers (Basel)2021
34672208Electrolyte and renal disorders in patients with newly diagnosed glioblastoma.Future Oncol2021
34544359CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience.J Headache Pain2021
33937037Case Report: Pseudomeningeosis and Demyelinating Metastasis-Like Lesions From Checkpoint Inhibitor Therapy in Malignant Melanoma.Front Oncol2021
34030742Simultaneous paraneoplastic cerebellar degeneration, Lambert-Eaton syndrome and neuropathy associated with AGNA/anti-SOX1 and VGCC antibodies.Neurol Res Pract2021
34026655Tumor Treating Fields for Glioblastoma Therapy During the COVID-19 Pandemic.Front Oncol2021
34162860Tumor-associated hematopoietic stem and progenitor cells positively linked to glioblastoma progression.Nat Commun2021
33113214MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA-09 trial.Int J Cancer2021
33398537Correction to: Global postâ¿¿marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with highâ¿¿grade glioma in clinical practice.J Neurooncol2021
33158630Demographic, radiographic, molecular and clinical characteristics of primary gliosarcoma and differences to glioblastoma.Clin Neurol Neurosurg2021
32535723Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice.J Neurooncol2020
33616939Severe ulcerations in corticosteroid-induced striae distensae rubrae under anti-vascular endothelial growth factor treatment of anaplastic astrocytoma.Int J Dermatol2020
33506201Preoperative and early postoperative seizures in patients with glioblastoma-two sides of the same coin?Neurooncol Adv2020
31672557To resect or not to resect? Risks and benefits of surgery in older patients with glioblastoma.J Geriatr Oncol2020
31811342Non-invasive tumor decoding and phenotyping of cerebral gliomas utilizing multiparametric <sup>18</sup>F-FET PET-MRI and MR Fingerprinting.Eur J Nucl Med Mol Imaging2020
31831598Olfactory function as an independent prognostic factor in glioblastoma.Neurology2020
32014969Preoperative Survival Prediction in Patients With Glioblastoma by Routine Inflammatory Laboratory Parameters.Anticancer Res2020
31828428Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma.J Cancer Res Clin Oncol2020
  • 1 - 50 of 133

Recommended Authors

Malaka Ameratunga
Australia Central Clinical School, Monash University
Career Start Year 2014
Number of shared co-authors 0
Priya Kumthekar
Northwestern University, Feinberg School of Medicine
Career Start Year 2013
Number of shared co-authors 6
Martha Nowosielski
Medical University of Innsbruck
Career Start Year 2009
Number of shared co-authors 7
Yoshua Esquenazi
McGovern Medical School at UT Health Houston
Career Start Year 2007
Number of shared co-authors 1
Josef Pichler
Kepler University Hospital
Career Start Year 2006
Number of shared co-authors 11
Adam M Sonabend
Northwestern University
Career Start Year 2005
Number of shared co-authors 3
Sherise D Ferguson
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 0
Nicholas Butowski
University of California san francisco
Career Start Year 2005
Number of shared co-authors 9
Thomas J Kaley
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 8
Marco Skardelly
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 2002
Number of shared co-authors 7
Andrew P Morokoff
Clinical Sciences Building, The University of Melbourne, The Royal Melbourne Hospital
Career Start Year 2001
Number of shared co-authors 0
Chul-Kee Park
College of Medicine, Seoul National University
Career Start Year 2000
Number of shared co-authors 6
Tracy T Batchelor
Brigham and Women's Hospital
Career Start Year 1996
Number of shared co-authors 9
Warren P Mason
Princess Margaret Cancer Centre
Career Start Year 1996
Number of shared co-authors 7
Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Career Start Year 1996
Number of shared co-authors 9
Erik P Sulman
NYU Grossman School of Medicine
Career Start Year 1995
Number of shared co-authors 10
Clark C Chen
University of Minnesota
Career Start Year 1994
Number of shared co-authors 5
David M Peereboom
Brain Tumor & Neuro-Oncology Cleveland Clinic Main Campus
Career Start Year 1993
Number of shared co-authors 4
Timothy F Cloughesy
David Geffen School of Medicine, University of California Los Angeles
Career Start Year 1992
Number of shared co-authors 10
Howard A Fine
Meyer Cancer Center
Career Start Year 1990
Number of shared co-authors 3
G??nther Stockhammer
Medical University of Innsbruck
Career Start Year 1990
Number of shared co-authors 4
Howard Colman
Huntsman Cancer Institute, University of Utah
Career Start Year 1990
Number of shared co-authors 12
Tom Mikkelsen
Ontario Brain Institute
Career Start Year 1990
Number of shared co-authors 13
Morris D Groves
The University of Texas MD Anderson Cancer Center
Career Start Year 1989
Number of shared co-authors 4
Motoo Nagane
Kyorin University Faculty of Medicine
Career Start Year 1988
Number of shared co-authors 3
Camilo E Fadul
University of Virginia Health System
Career Start Year 1987
Number of shared co-authors 0
Michael D Prados
University of California san francisco
Career Start Year 1987
Number of shared co-authors 7
Ryo Nishikawa
Saitama Medical University International Medical Center
Career Start Year 1986
Number of shared co-authors 7
Michael A Vogelbaum
Moffit Cancer Center
Career Start Year 1986
Number of shared co-authors 8
Wai-Kwan Alfred Yung
University of Texas M.D. Anderson Cancer Center
Career Start Year 1974
Number of shared co-authors 8

Collaborators

Bj??rn Scheffler
German Cancer Research Center (DKFZ)
Co-authored papers 46
Theophilos Tzaridis
Co-authored papers 17
Michael Weller
University Hospital and University of Zurich
Co-authored papers 10
Torsten Pietsch
Co-authored papers 10
Guido Reifenberger
Heinrich Heine University
Co-authored papers 10
Ghazaleh Tabatabai
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Co-authored papers 8
Hartmut Vatter
University Hospital Bonn
Co-authored papers 7
Andreas Till
University Hospital Bonn
Co-authored papers 6
Peter Vajkoczy
Charite - Universitatsmedizin Berlin
Co-authored papers 4
Andreas von Deimling
Co-authored papers 4
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 2
Peter Lichter
German Cancer Research Center (DKFZ)
Co-authored papers 2
Holger Fr??hlich
Bonn-Aachen International Center for IT (B-IT), University of Bonn
Co-authored papers 2
Dirk Schadendorf
Co-authored papers 2
Charles G Eberhart
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Co-authored papers 2
David Capper
Charite University Medicine Berlin
Co-authored papers 2
David T W Jones
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 2
Nancy Ann Oberheim Bush
University of California san francisco
Co-authored papers 2
Martin Kolnik
Miltenyi Biotec Inc.
Co-authored papers 1
Andreas Buness
Co-authored papers 1
Jingjing Liu
College of Tropical Crops, Hainan University
Co-authored papers 1
Erdem G??resir
University of Leipzig Medical Center
Co-authored papers 1
Robert J Wechsler-Reya
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 1
Suresh Subramani
University of California San Diego
Co-authored papers 1
Sebastian Brandner
UCL Queen Square Institute of Neurology
Co-authored papers 1
Frauke Zipp
Co-authored papers 1
Rintaro Saito
Institute for Advanced Biosciences, Keio University
Co-authored papers 1
Jill S Barnholtz-Sloan
National Cancer Institute
Co-authored papers 1
Christel Herold-Mende
Co-authored papers 1
Gelareh Zadeh
University of Toronto
Co-authored papers 1
Release 1.2